Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 3/20 | 0.50 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.50 |
| ▸ | ITGB3 | P05106 | 5/20 | 0.49 |
| ▸ | ITGA2B | P08514 | 5/20 | 0.49 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26870168 | 0.96 | PRMT1 (0.55) | EPHX2PRMT1ITGB3ITGA2BADRA1A | |
| SCHEMBL3986924 | 0.96 | PRMT1 (0.55) | EPHX2PRMT1ITGB3ITGA2BADRA1A | |
| SCHEMBL8770877 | 0.96 | PRMT1 (0.55) | EPHX2PRMT1ITGB3ITGA2BADRA1A | |
| Dodecanoate SCHEMBL2900244 | 0.92 | EPHX2 (0.62) | EPHX2KDM4ETSHRFAAHCNR1 | |
| SCHEMBL20999515 | 0.91 | ITGB3 (0.54) | EPHX2PRMT1ITGB3ITGA2BADRA1A | |
| Dodecanoate SCHEMBL6938811 | 0.89 | EPHX2 (0.67) | EPHX2KDM4EFAAHCNR1CNR2 | |
| SCHEMBL5538332 | 0.89 | PRMT1 (0.63) | EPHX2PRMT1ITGB3ITGA2BADRA1A | |
| SCHEMBL5535532 | 0.89 | PRMT1 (0.63) | EPHX2PRMT1ITGB3ITGA2BADRA1A | |
| SCHEMBL5533492 | 0.89 | PRMT1 (0.63) | EPHX2PRMT1ITGB3ITGA2BADRA1A | |
| SCHEMBL5533323 | 0.89 | PRMT1 (0.63) | EPHX2PRMT1ITGB3ITGA2BADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0617705-B1 | NON-PEPTIDIC SURROGATES OF THE ARG-GLY-ASP SEQUENCE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | YEDA RES & DEV (IL) | 1997-09-24 | — | — | EP | disclosed |
| US-5519005-A | GUANIDINE TERMINATED PEPTIDES FOR TREATMENT OF THROMBOSIS, ANTITUMOR AGENTS, AUTOIMMUNE DISEASES AND IMMUNOLOGY | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1996-05-21 | — | — | US | disclosed |
| EP-0617705-A4 | NON-PEPTIDIC SURROGATES OF THE ARG-GLY-ASP SEQUENCE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM. | YEDA RES & DEV (IL) | 1994-12-28 | — | — | EP | disclosed |
| EP-0617705-A1 | NON-PEPTIDIC SURROGATES OF THE ARG-GLY-ASP SEQUENCE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM. | YEDA RES & DEV (IL) | 1994-10-05 | — | — | EP | disclosed |
| US-5352667-A | Inhibit cell adhesion | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1994-10-04 | — | — | US | disclosed |
| WO-1993009795-A1 | NON-PEPTIDIC SURROGATES OF THE ARG-GLY-ASP SEQUENCE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1993-05-27 | — | — | WO | disclosed |